Product
TY-2699a
1 clinical trial
2 indications
Indication
Solid TumorIndication
AdultClinical trial
A Phase I, Multicenter, Open-label Study of TY-2699a, Administered Orally in Adult Patients With Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2025-10-01